Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells

American Journal of Pathology

Volumn 171, Issue 1, 2007, Pages 304-314

  Wang, Xinwen ^a   Mu, Hong ^a   Chai, Hong ^a   Liao, Dan ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; APOLIPOPROTEIN A1; CAVEOLIN 1; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RITONAVIR; SCAVENGER RECEPTOR BI; SUPEROXIDE; ADENOSINE TRIPHOSPHATE; ANION; CHOLESTEROL; MULTIENZYME COMPLEX; OXIDOREDUCTASE; PROTEINASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FOAM CELL; GENE SEQUENCE; HUMAN; HUMAN CELL; MACROPHAGE; MEMBRANE POTENTIAL; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL;

ADENOSINE TRIPHOSPHATE; ANIONS; CAVEOLIN 1; CELLS, CULTURED; CHOLESTEROL; FOAM CELLS; HIV PROTEASE INHIBITORS; HUMANS; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASE 3; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; RITONAVIR; SCAVENGER RECEPTORS, CLASS B; SUPEROXIDES;

EID: 34547689728     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060965     Document Type: Article

References (42)

1. Navia MA, Fitzgerald PM, McKeever BM, Leu CT, Heimbach JC, Herber WK, Sigal IS, Darke PL, Springer JP: Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 1989, 337:615-620
2. Shankar SS, Dube MP: Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents. Cardiovasc Toxicol 2004, 4:261-269
3. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860
4. Sviridov D, Nestel P: Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002, 161:245-254
5. Ohashi R, Mu H, Wang X, Yao Q, Chen C: Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005, 98:845-856
6. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G: ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 2000, 97:817-822
7. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999, 22:347-351
8. de La Llera-Moya M, Connelly MA, Drazul D, Klein SM, Favari E, Yancey PG, Williams DL, Rothblat GH: Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res 2001, 42:1969-1978
9. Arakawa R, Abe-Dohmae S, Asai M, Ito JI, Yokoyama S: Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J Lipid Res 2000, 41:1952-1962
10. Escher G, Krozowski Z, Croft KD, Sviridov D: Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J Biol Chem 2003, 278:11015-11019
11. Gesquière L, Loreau N, Minnich A, Davignon J, Blache D: Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radio Biol Med 1999, 27:134-145
12. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
13. Dressman J, Kincer J, Matveev SV, Guo L, Greenberg RN, Guerin T, Meade D, Li XA, Zhu W, Uittenbogaard A, Wilson ME, Smart EJ: HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest 2003, 111:389-397
14. Chai H, Zhou W, Lin P, Lumsden A, Yao Q, Chen C: Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries. Am J Physiol 2005, 288:H2965-H2971
15. Chai H, Yan S, Lin P, Lumsden AB, Yao Q, Chen C: Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg 2005, 200:820-830
16. Chen C, Lu XH, Yan S, Chai H, Yao Q: HIV protease inhibitor ritonavir increases endothelial monolayer permeability. Biochem Biophys Res Commun 2005, 335:874-382
17. Conklin BS, Fu W, Lin PH, Lumsden AB, Yao Q, Chen C: HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries. Cardiovasc Res 2004, 63:168-175
18. Fu W, Chai H, Yao Q, Chen C: Effects of HIV protease inhibitor ritonavir on vasomotor function and endothelial nitric oxide synthase expression. J Acquir Immune Defic Syndr 2005, 39:152-158
19. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001, 104:257-262
20. Palmer AM, Murphy N, Graham A: Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells. Atherosclerosis 2004, 173:27-38
21. Wang X, LeMaire SA, Chen L, Shen Y, Gan Y, Utama B, Ou H, Bartsch H, Carter S, Coselli J, Wang XL: Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 2006, 114:1200-1205
22. Matés JM, Perez-Gomez C, Nunez de Castro I: Antioxidant enzymes and human diseases. Clin Biochem 1999, 32:595-603
23. Matés JM, Sanchez-Jimenez F: Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999, 4.D339-D345
24. Maggi P, Serio G, Epifani G, Fiorentino G, Saracino A, Fico C, Perilli F, Lillo A, Ferraro S, Gargiulo M, Chirianni A, Angarano G, Regina G, Pastore G: Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 2000, 14:F123-F128
25. Deeks SG, Smith M, Holodniy M, Kahn JO: HIV-1 protease inhibitors. A review for clinicians. JAMA 1997, 277:145-153
26. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, Brewer Jr HB: Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 2001. 280:818-823
27. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, Xu S, Krieger M: Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997, 272:13242-13249
28. Frank PG, Marcel YL, Connelly MA, Lublin DM, Franklin V, Williams DL, Lisanti MP: Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 2002, 41:11931-11940
29. Wang L, Connelly MA, Ostermeyer AG, Chen HH, Williams DL, Brown DA: Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J Lipid Res 2003, 44:807-815
30. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328:1450-1456
31. Genova ML, Pich MM, Bernacchia A, Bianchi C, Biondi A, Bovina C, Falasca AI, Formiggini G, Castelli GP, Lenaz G: The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann NY Acad Sci 2004, 1011:86-100
32. Baranova I, Vishnyakova T, Bocharov A, Chen Z, Remaley AT, Stonik J, Eggerman TL, Patterson AP: Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 2002, 70:2995-3003
33. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J: Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 2005, 145:323-333
34. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, Berk BC: Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 1999, 85:29-37
35. - in vascular smooth muscle cells. Circ Res 1995, 77:29-36
36. Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G: Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 2006, 47:794-803
37. Nofer JR, Feuerborn R, Levkau B, Sokoll A, Seedorf U, Assmann G: Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 2003, 278:53055-53062
38. Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, Freeman MW: ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 2004, 45:287-294
39. Haidar B, Denis M, Krimbou L, Marcil M, Genest Jr J: cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 2002, 43:2087-2094
40. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 2003, 44:1728-1736
41. Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65
42. Chen M, Li W, Wang N, Zhu Y, Wang X: ROS and NF-κB but not LXR mediate IL-1β signaling for the downregulation of ATP-binding cassette transporter A1. Am J Physiol Cell Physiol 2007, 292:C1493-C1501